We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Provectus Biopharmaceuticals Inc (QB) | USOTC:PVCT | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00175 | 0.91% | 0.19305 | 0.0001 | 0.199 | 0.198 | 0.1901 | 0.198 | 128,865 | 21:15:26 |
Delaware
|
001-36457
|
90-0031917
|
(State or other jurisdiction
|
(Commission
|
(IRS Employer
|
of incorporation)
|
File Number)
|
Identification No.)
|
7327 Oak Ridge Hwy., Knoxville, Tennessee 37931
|
(Address of Principal Executive Offices)
|
(866) 594-5999
|
(Registrant’s Telephone Number, Including Area Code)
(Former Name or Former Address, If Changed Since Last Report)
|
□
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
□
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
□
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
□ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 7.01.
|
Regulation FD Disclosure.
|
|
PROVECTUS BIOPHARMACEUTICALS, INC.
|
By: | /s/ Peter R. Culpepper |
Peter R. Culpepper | |
Chief Financial Officer and Chief Operating Officer |
|
EXHIBIT INDEX
|
Exhibit Number
|
Description
|
|
99.1
|
Press release dated May 27, 2014
|
Contact: | |
Provectus Biopharmaceuticals, Inc. | Porter, LeVay & Rose, Inc. |
Peter R. Culpepper, CFO, COO | Marlon Nurse, DM, SVP – Investor Relations |
Phone: 866-594-5999 #30 | Phone: 212-564-4700 |
Bill Gordon – Media Relations | |
Phone: 212-724-6312 |
1 Year Provectus Biopharmaceuti... (QB) Chart |
1 Month Provectus Biopharmaceuti... (QB) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions